zalika

Novos testes rápidos de antígeno podem transformar resposta à COVID-19 nas Américas

News

Novos testes rápidos de antígeno podem transformar resposta à COVID-19 nas Américas

By Zalika Famaceutica|2022-09-10T18:10:52-03:00October 16, 2020|News|

[:en]FDA Approves Nivolumab Plus Ipilimumab for the First-Line Treatment of Unresectable Malignant Pleural Mesothelioma[:]

News

[:en]FDA Approves Nivolumab Plus Ipilimumab for the First-Line Treatment of Unresectable Malignant Pleural Mesothelioma[:]

By Zalika Famaceutica|2022-09-10T18:10:53-03:00October 6, 2020|News|

[:en]Coronavirus: Serum Institute gets drugs regulator approval to resume India trials of Oxford vaccine[:]

News

[:en]Coronavirus: Serum Institute gets drugs regulator approval to resume India trials of Oxford vaccine[:]

By Zalika Famaceutica|2022-09-10T18:10:55-03:00September 17, 2020|News|

Come to Brazil with Zalika

ESCRITÓRIO REGISTRADO

Rua Turiassú, 145, Cj 121-122
Perdizes – São Paulo-SP
05005-001 – Brasil

CENTRO TÉCNICO

Rua Chopin, 33, Chácaras Reunidas Santa Terezinha
Contagem – MG
32183-150 – Brasil

GET IN TOUCH

+55 (11) 2362-0552

info@zalikafarmaceutica.com

© 2022 – All rights reserved. • Zalika Farmacêutica • Powered by Daniel